Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,850 | -24,980 | -30,230 | -21,180 | 0 |
| Depreciation Amortization | 850 | 830 | 840 | 710 | 0 |
| Other Working Capital | -3,990 | 8,820 | 4,200 | 450 | 0 |
| Other Operating Activity | -20 | -80 | 10 | 10 | 0 |
| Operating Cash Flow | $-23,010 | $-15,410 | $-25,180 | $-20,010 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -160 | -420 | -820 | -630 | 0 |
| Net Acquisitions | 0 | -8,660 | 0 | 0 | 0 |
| Other Investing Activity | 21,300 | -10 | -18,210 | 21,210 | 0 |
| Investing Cash Flow | $21,140 | $-9,090 | $-19,030 | $20,580 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -7,190 | 32,950 | 46,160 | 440 | 0 |
| Financing Cash Flow | $-7,190 | $32,950 | $46,160 | $440 | $0 |
| Exchange Rate Effect | 20 | 80 | 0 | 0 | 0 |
| Beginning Cash Position | 14,420 | 6,180 | 4,490 | 3,490 | 0 |
| End Cash Position | 5,380 | 14,720 | 6,440 | 4,500 | 0 |
| Net Cash Flow | $-9,040 | $8,530 | $1,950 | $1,010 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,010 | -15,410 | -25,180 | -20,010 | 0 |
| Free Cash Flow | -23,010 | -15,410 | -25,180 | -20,010 | 0 |